We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

13 hedge funds and large institutions have $982K invested in Eterna Therapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more capital invested

Capital invested by funds: $637K → $982K (+$345K)

44% more funds holding

Funds holding: 9 → 13 (+4)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
13
Holders Change
+4
Holders Change %
+44.44%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCA
Sippican Capital Advisors
Massachusetts
+$34.5K
2
AWE
Avidian Wealth Enterprises
Texas
+$26.9K
3
Citadel Advisors
Citadel Advisors
Florida
+$18.6K
4
Renaissance Technologies
Renaissance Technologies
New York
+$18.6K
5
UBS Group
UBS Group
Switzerland
+$1.38K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$690
2
PWA
Provenance Wealth Advisors
Florida
-$27
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
CPWM
1
Cypress Point Wealth Management
Texas
$227K – – –
NW
2
Naviter Wealth
Arkansas
$189K – – –
SCA
3
Sippican Capital Advisors
Massachusetts
$175K +$34.5K +50 +35%
Corient Private Wealth
4
Corient Private Wealth
Florida
$120K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$62.6K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$53.8K – – –
BlackRock
7
BlackRock
New York
$37.5K – – –
AWE
8
Avidian Wealth Enterprises
Texas
$35.5K +$26.9K +39 New
Citadel Advisors
9
Citadel Advisors
Florida
$24.1K +$18.6K +27 New
Renaissance Technologies
10
Renaissance Technologies
New York
$24K +$18.6K +27 New
BWP
11
Baldwin Wealth Partners
Massachusetts
$20.5K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$9.8K -$690 -1 -8%
UBS Group
13
UBS Group
Switzerland
$1.78K +$1.38K +2 New
NS
14
NBC Securities
Alabama
$1K – – –
MA
15
Montag & Associates
Georgia
$339 – – –
Morgan Stanley
16
Morgan Stanley
New York
$120 – – –
Wells Fargo
17
Wells Fargo
California
$67 – – –
Group One Trading
18
Group One Trading
Illinois
$45 – – –
Citigroup
19
Citigroup
New York
$36 – – –
JP Morgan Chase
20
JP Morgan Chase
New York
$33 – – –
APC
21
Aspire Private Capital
North Carolina
$24 – – –
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
$10 – – –
Fidelity Investments
23
Fidelity Investments
Massachusetts
– -$2 – –
PWA
24
Provenance Wealth Advisors
Florida
– -$27 – –

ERNA Hedge Fund Activity: Q1 2024 in Review

13 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q1 2024, worth a combined $982K — up 54% from $637K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ERNA positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Sippican Capital Advisors, adding an estimated $34.5K. The largest seller was Tower Research Capital (TRC), cutting an estimated $690.

  • 13 institutional investors held Eterna Therapeutics (ERNA) as of Q1 2024, up from 9 in Q4 2023.
  • Funds reported $982K of Eterna Therapeutics stock for Q1 2024, up 54% quarter-over-quarter.
  • 4 funds opened new Eterna Therapeutics positions in Q1 2024 and 0 closed out, a net change of +4 holders.
  • The largest Eterna Therapeutics buyer in Q1 2024 was Sippican Capital Advisors, an estimated $34.5K added.
  • The largest Eterna Therapeutics seller in Q1 2024 was Tower Research Capital (TRC), an estimated $690 sold.

Based on aggregated 13F filings for Q1 2024.